The Scientist - Home

Oligomannate, recently approved in China, is being met with some skepticism from researchers.

Inhaling combustion-produced particles may lead to the development of brain tumors.

The country’s new government appears to have heard the call from academics for an independent body to distribute federal research funds.

Members of two geology societies voiced concerns about the school’s prohibition of same-sex relationships.

The US Food and Drug Administration halts a study by Solid Biosciences after a patient experiences severe side effects following treatment.

The changes would further restrict which scientific findings can be used in drafting regulations.

Criticism of the paper first surfaced in 1994, and its author was accused of scientific misconduct.

Merck’s Ervebo gets its first regulatory greenlight. A decision from the US Food and Drug Administration is expected in the next few months.

The chemical was found in all 29 lung fluid samples tested.

TAK-003 appears to avoid the safety issues seen with an existing vaccine, but experts say a longer evaluation is needed.

After a series of appeals from the university, Missouri courts have ruled for the third time that students have collective bargaining rights.

Dropping the transcription factor from the four so-called Yamanaka factors reduces the efficiency of inducing the production of stem cells, but the resulting cells are of greater quality.